BRGA.Y Stock Overview
Engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
Borregaard ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 35.15 |
| 52 Week High | NOK 38.09 |
| 52 Week Low | NOK 28.00 |
| Beta | 0.50 |
| 11 Month Change | 0% |
| 3 Month Change | -0.99% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 132.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| BRGA.Y | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 0% | 2.5% | 2.2% |
| 1Y | n/a | 11.6% | 31.6% |
Return vs Industry: Insufficient data to determine how BRGA.Y performed against the US Chemicals industry.
Return vs Market: Insufficient data to determine how BRGA.Y performed against the US Market.
Price Volatility
| BRGA.Y volatility | |
|---|---|
| BRGA.Y Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BRGA.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BRGA.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 1,127 | Per Sørlie | www.borregaard.com |
Borregaard ASA engages in the development, production, and marketing of specialized biomaterials and biochemicals in Norway, rest of Europe, the United States, Asia, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers for various applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry.
Borregaard ASA Fundamentals Summary
| BRGA.Y fundamental statistics | |
|---|---|
| Market cap | US$1.66b |
| Earnings (TTM) | US$72.61m |
| Revenue (TTM) | US$657.42m |
22.8x
P/E Ratio2.5x
P/S RatioIs BRGA.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BRGA.Y income statement (TTM) | |
|---|---|
| Revenue | NOK 7.24b |
| Cost of Revenue | NOK 2.68b |
| Gross Profit | NOK 4.57b |
| Other Expenses | NOK 3.77b |
| Earnings | NOK 800.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 8.02 |
| Gross Margin | 63.05% |
| Net Profit Margin | 11.05% |
| Debt/Equity Ratio | 39.3% |
How did BRGA.Y perform over the long term?
See historical performance and comparison